Akzo Nobel NV (AKZA)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 60.02 |
|---|---|
| 52-week range | 46.18 – 67.64 |
| Return, 1 month / 3 months | +4.4% / +3.2% |
| Return, 1 year / 3 years | +2.8% / +4.7% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 37.6% |
| Worst drawdown (1 year) | -23.3% |
| Average daily value traded | 27.79M EUR |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Akzo Nobel is a Dutch paints and coatings company based in Amsterdam. It makes decorative paints for households and professional painters, sold under brands such as Dulux and Sikkens, and it produces performance coatings used in industry, shipping, automotive refinishing and construction. Its customers range from do-it-yourself consumers and trade painters to manufacturers and industrial firms, and it serves markets around the world.
On this site Akzo Nobel NV appears as a stock on the Euronext Amsterdam (Netherlands), code AKZA, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Akzo Nobel NV (AKZA) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 60.02 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 37 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.8% and over the last three months it rose 3.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.5% | ||
| From 52-week high | -9.7% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.2% | ||
| 6-month return | 15.5% | ||
| 12-month return, skipping the last month | -1.5% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.3% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 27.79M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | +4.4% |
| 3 months | +3.2% |
| 6 months | +15.5% |
| 1 year | +2.8% |
| 3 years | +4.7% |
| 5 years | −27.6% |
Signals
| 50-day / 200-day average | 58.84 / 56.36 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Apr 2026 | EUR 1.5400 |
| 27 Oct 2025 | EUR 0.4400 |
| 29 Apr 2025 | EUR 1.5400 |
| 28 Oct 2024 | EUR 0.4400 |
| 29 Apr 2024 | EUR 1.5400 |
| 30 Oct 2023 | EUR 0.4400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.